DeepMed Research

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

Conditions: Cardiovascular Events
Type2 Diabetes
Renal Disease

Interventions: Drug: GLP-1RA
Drug: SGLT2 inhibitor
Drug: DPP-4 inhibitor
Drug: 2nd generation SU

First Posted Date: 2022-02-02

Last Posted Date: 2022-02-18

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 781430

Registration Number: NCT05220917

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Proof-of-Concept Trial of a Positive Psychology Intervention for Caregivers of Patients Undergoing HSCT

Not Applicable

Completed

Conditions: Caregiver
Hematologic Malignancy

Interventions: Behavioral: Positive Psychology Intervention

First Posted Date: 2022-02-01

Last Posted Date: 2024-07-01

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 23

Registration Number: NCT05216978

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Advance Care Planning in the Emergency Department

Not Applicable

Completed

Conditions: Congestive Heart Failure
Metastatic Cancer
Chronic Kidney Disease Requiring Chronic Dialysis
Chronic Obstructive Pulmonary Disease

Interventions: Behavioral: ED GOAL

First Posted Date: 2022-01-27

Last Posted Date: 2025-05-06

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 141

Registration Number: NCT05209880

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

The Effects of a Virtual Yoga Program on Patients With Chronic Pain

Not Applicable

Recruiting

Conditions: Chronic Pain

Interventions: Behavioral: Yoga Based Daily Excercise

First Posted Date: 2022-01-27

Last Posted Date: 2023-08-15

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 42

Registration Number: NCT05211414

Locations: 🇺🇸
Brigham and Women's Hospital, Chestnut Hill, Massachusetts, United States

Replication of the INSPIRE Trial in Healthcare Claims Data

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: salmeterol-fluticasone
Drug: Tiotropium

First Posted Date: 2022-01-05

Last Posted Date: 2023-07-27

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 98278

Registration Number: NCT05179512

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Decreasing Unnecessary Antibiotics Prescribed for Possible Pneumonia Despite Normal Respiratory Rate and Oxygenation

Not Applicable

Conditions: Pneumonia

Interventions: Behavioral: Antibiotic stewardship messaging

First Posted Date: 2021-12-29

Last Posted Date: 2023-08-25

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 2000

Registration Number: NCT05172791

Locations: 🇺🇸
Brigham and Womens Hospital, Boston, Massachusetts, United States

Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants

Not Applicable

Recruiting

Conditions: Genetic Predisposition to Disease
Hereditary Diseases

Interventions: Genetic: Genome Sequencing

First Posted Date: 2021-12-17

Last Posted Date: 2024-05-16

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 500

Registration Number: NCT05161169

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸
Beaumont - Corewell Health East, Royal Oak, Michigan, United States

and more 1 locations

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Recruiting

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: GLP-1 receptor agonist
Drug: DPP4
Drug: SU
Drug: SLGT2
Drug: Basal Insulin

First Posted Date: 2021-12-17

Last Posted Date: 2023-06-22

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 550000

Registration Number: NCT05161429

Locations: 🇺🇸
HealthCore, Inc., Wilmington, Delaware, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Humana, Lexington, Kentucky, United States

and more 2 locations

Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data

Completed

Conditions: Diabetes

Interventions: Drug: Glimepiride
Drug: Liraglutide

First Posted Date: 2021-12-17

Last Posted Date: 2023-07-27

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 3474

Registration Number: NCT05162183

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Prevalence of Sleep Apnea and Atrial Fibrillation

Conditions: Atrial Fibrillation
Sleep Apnea

First Posted Date: 2021-12-14

Last Posted Date: 2022-06-07

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 300

Registration Number: NCT05155813

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy